top of page
< Back

Pegaspargase


Mechanism of action:

Pegaspargase is a PEGylated L-asparaginase. Pegaspargase breaks down L-asparagine into L-aspartic acid and ammonia, causing a marked reduction in plasma L-asparagine levels. Leukemic lymphoblasts usually lack asparagine synthetase and are therefore highly dependent on exogenous asparagine. When plasma L-asparagine is depleted, leukemic lymphoblasts are unable to synthesize proteins.

Reference(s):

1. Graham ML et al. (2003). Pegaspargase: a review of clinical studies. Adv Drug Deliv Rev. 


2. Zeidan A et al. (2009). Pegasparaginase: where do we stand? Expert Opin Biol Ther. 


3. Heo YA et al. (2019). Pegaspargase: A Review in Acute Lymphoblastic Leukaemia. Drugs.

bottom of page